Basilea Pharmaceutica AG (LON:0QNA)
London · Delayed Price · Currency is GBP · Price in CHF 48.65
+0.05 (0.10%)
At close: Oct 21, 2025
Basilea Pharmaceutica AG Market Cap
Basilea Pharmaceutica AG has a market cap or net worth of 561.13 million as of October 22, 2025. Its market cap has increased by 15.26% in one year.
Market Cap
561.13M
Enterprise Value
531.43M
Revenue
216.79M
Ranking
n/a
PE Ratio
8.41
Stock Price
48.65
Market Cap Chart
Since March 25, 2004, Basilea Pharmaceutica AG's market cap has increased from 231.10M to 561.13M, an increase of 142.81%. That is a compound annual growth rate of 4.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2025 | 561.63M | 27.18% |
| Dec 30, 2024 | 441.59M | 12.00% |
| Dec 29, 2023 | 394.28M | -19.52% |
| Dec 30, 2022 | 489.93M | 24.72% |
| Dec 30, 2021 | 392.83M | -17.81% |
| Dec 30, 2020 | 477.95M | 20.82% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 194.46B |
| GSK plc | 66.17B |
| Haleon | 31.07B |
| Smith & Nephew | 11.59B |
| ConvaTec Group | 4.95B |
| Hikma Pharmaceuticals | 3.95B |
| HUTCHMED (China) | 1.89B |
| Genus | 1.74B |